about us:


Olon S.p.A. is a worldwide leader in the development and production of APIs (Active Pharmaceutical Ingredients). The ideal partner for custom synthesis and contract manufacturing projects.

news & events:


InformEx 2015 - February 3 - 5  New Orleans (USA)

Visit us at booth # 1826

products search:


focus on:


POMALIDOMIDE

Olon S.p.A. has recently included Pomalidomide among its R&D development projects. The product is a cytostatic compound that will therefore reinforce our current portfolio already including bicalutamide and thalidomide.

OSPEMIFENE

Olon S.p.A. has recently included Ospemifene among its R&D development projects. The product will complete our portfolio already including raloxifene, tamoxifene, toremifene and bazedoxifene.